122 related articles for article (PubMed ID: 28962866)
1. In vitro metabolism of 4, 5-dimethoxycanthin-6-one by human liver microsomes and its inhibition on human CYP1A2.
Miao X; You J; Wang J; Chen Y
Life Sci; 2017 Dec; 190():46-51. PubMed ID: 28962866
[TBL] [Abstract][Full Text] [Related]
2. The inhibition of CYP1A2, CYP2C9, and CYP2D6 by pterostilbene in human liver microsomes.
Albassam AA; Ahad A; Alsultan A; Yusufoglu HS; Foudah AI; Al-Jenoobi FI
Pharmazie; 2021 Apr; 76(4):155-158. PubMed ID: 33849700
[TBL] [Abstract][Full Text] [Related]
3. In vitro inhibitory effect of piperlonguminine isolated from Piper longum on human cytochrome P450 1A2.
Song M; Hwang JY; Lee MY; Jee JG; Lee YM; Bae JS; Kim JA; Lee SH; Lee S
Arch Pharm Res; 2014 Aug; 37(8):1063-8. PubMed ID: 24194261
[TBL] [Abstract][Full Text] [Related]
4. Identification of in vivo and in vitro metabolites of 4,5-dimethoxycanthin-6-one by HPLC-Q-TOF-MS/MS.
Miao X; Wang J; Chen L; Peng Z; Chen Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 May; 1020():78-84. PubMed ID: 27030894
[TBL] [Abstract][Full Text] [Related]
5. Effects of Radix Astragali and Radix Rehmanniae, the components of an anti-diabetic foot ulcer herbal formula, on metabolism of model CYP1A2, CYP2C9, CYP2D6, CYP2E1 and CYP3A4 probe substrates in pooled human liver microsomes and specific CYP isoforms.
Or PM; Lam FF; Kwan YW; Cho CH; Lau CP; Yu H; Lin G; Lau CB; Fung KP; Leung PC; Yeung JH
Phytomedicine; 2012 Apr; 19(6):535-44. PubMed ID: 22261394
[TBL] [Abstract][Full Text] [Related]
6. The inhibitory activity of the extracts of popular medicinal herbs on CYP1A2, 2C9, 2C19 and 3A4 and the implications for herb-drug interaction.
Fasinu PS; Bouic PJ; Rosenkranz B
Afr J Tradit Complement Altern Med; 2014; 11(4):54-61. PubMed ID: 25392581
[TBL] [Abstract][Full Text] [Related]
7. A predominate role of CYP1A2 for the metabolism of nabumetone to the active metabolite, 6-methoxy-2-naphthylacetic acid, in human liver microsomes.
Turpeinen M; Hofmann U; Klein K; Mürdter T; Schwab M; Zanger UM
Drug Metab Dispos; 2009 May; 37(5):1017-24. PubMed ID: 19204080
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of reactive metabolites in myristicin-mediated mechanism-based inhibition of CYP1A2.
Yang AH; He X; Chen JX; He LN; Jin CH; Wang LL; Zhang FL; An LJ
Chem Biol Interact; 2015 Jul; 237():133-40. PubMed ID: 26091900
[TBL] [Abstract][Full Text] [Related]
9. Searching the cytochrome p450 enzymes for the metabolism of meranzin hydrate: a prospective antidepressant originating from Chaihu-Shugan-San.
Huang X; Guo Y; Huang WH; Zhang W; Tan ZR; Peng JB; Wang YC; Hu DL; Ouyang DS; Xiao J; Wang Y; Luo M; Chen Y
PLoS One; 2014; 9(11):e113819. PubMed ID: 25427198
[TBL] [Abstract][Full Text] [Related]
10. The inhibitory effect of polyunsaturated fatty acids on human CYP enzymes.
Yao HT; Chang YW; Lan SJ; Chen CT; Hsu JT; Yeh TK
Life Sci; 2006 Nov; 79(26):2432-40. PubMed ID: 16978661
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of cytochrome P450 enzymes CYP1A2, CYP2A6, CYP2E1 and CYP3A4 by extracts and alkaloids of Gelsemium elegans roots.
Wang Y; Wu S; Chen Z; Zhang H; Zhao W
J Ethnopharmacol; 2015 May; 166():66-73. PubMed ID: 25764964
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of human drug metabolizing cytochromes P450 by anastrozole, a potent and selective inhibitor of aromatase.
Grimm SW; Dyroff MC
Drug Metab Dispos; 1997 May; 25(5):598-602. PubMed ID: 9152599
[TBL] [Abstract][Full Text] [Related]
13. Optimizing higher throughput methods to assess drug-drug interactions for CYP1A2, CYP2C9, CYP2C19, CYP2D6, rCYP2D6, and CYP3A4 in vitro using a single point IC(50).
Gao F; Johnson DL; Ekins S; Janiszewski J; Kelly KG; Meyer RD; West M
J Biomol Screen; 2002 Aug; 7(4):373-82. PubMed ID: 12230892
[TBL] [Abstract][Full Text] [Related]
14. Effect of Saccharolactone on CYP-mediated Metabolism of Xenobiotics.
Behera D; Jain P; Kurawattimath V; Gowda N
Drug Metab Bioanal Lett; 2023; 16(2):121-132. PubMed ID: 37612873
[TBL] [Abstract][Full Text] [Related]
15. Human cytochromes P450 mediating phenacetin O-deethylation in vitro: validation of the high affinity component as an index of CYP1A2 activity.
Venkatakrishnan K; von Moltke LL; Greenblatt DJ
J Pharm Sci; 1998 Dec; 87(12):1502-7. PubMed ID: 10189256
[TBL] [Abstract][Full Text] [Related]
16. [Metabolic detoxification of bakuchiol is mediated by cytochrome P450 enzymes in human liver microsomes].
Li AF; Shen GL; Jiao SY; Li H; Wang Q
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Jun; 44(3):431-6. PubMed ID: 22692316
[TBL] [Abstract][Full Text] [Related]
17. Stereoselective interaction between tetrahydropalmatine enantiomers and CYP enzymes in human liver microsomes.
Sun SY; Wang YQ; Li LP; Wang L; Zeng S; Zhou H; Jiang HD
Chirality; 2013 Jan; 25(1):43-7. PubMed ID: 23001793
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of antiarrhythmic drugs on phenacetin O-deethylation catalysed by human CYP1A2.
Kobayashi K; Nakajima M; Chiba K; Yamamoto T; Tani M; Ishizaki T; Kuroiwa Y
Br J Clin Pharmacol; 1998 Apr; 45(4):361-8. PubMed ID: 9578183
[TBL] [Abstract][Full Text] [Related]
19. Identification of the human liver cytochrome P450 isoenzymes responsible for the 5-methylhydroxylation of the novel anti-fibrotic drug AKF-PD.
He X; Luo X; Liu Z; Hu G; Cheng Z
Xenobiotica; 2011 Oct; 41(10):844-50. PubMed ID: 21679010
[TBL] [Abstract][Full Text] [Related]
20. Role of human microsomal and human complementary DNA-expressed cytochromes P4501A2 and P4503A4 in the bioactivation of aflatoxin B1.
Gallagher EP; Wienkers LC; Stapleton PL; Kunze KL; Eaton DL
Cancer Res; 1994 Jan; 54(1):101-8. PubMed ID: 8261428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
